glp 1 vendors GLP-1 Receptor Agonist Companies and Competitive Landscape Managing Compounded GLP-1 Medications: A

Glucagon-like peptide-1 in diabetes care: can glycaemic control be achieved without nausea and vomiting

Unique to Medicare, both GLP1s and SGLT2s have gained ground, making up 23% and 17% of the market respectively by mid2025

Maiorino, M., Gregolin, C

Eden does not manufacture or dispense medications but connects patients with licensed healthcare providers

Things To Know Both Ozempic and Trulicity are once-weekly injectable GLP-1 receptor agonists used to treat type 2 diabetes Ozempic contains semaglutide while Trulicity contains dulaglutide as their active ingredients Ozempic typically produces greater A1C reduction (up to 1.8%) compared to Trulicity (up to 1.5%) Weight loss tends to be more pronounced with Ozempic, averaging 10-15 pounds versus 5-7 pounds with Trulicity Both medications carry similar gastrointestinal side effects including nausea, vomiting, and diarrhea Trulicity offers higher maximum dosing (4.5mg) while Ozempic maxes out at 2mg weekly Neither medication is approved as a standalone weight loss treatment, though both cause weight reduction Switching between these medications requires medical supervision and proper dose titration How Do Ozempic and Trulicity Work